Literature DB >> 26520391

Receptome: Interactions between three pain-related receptors or the "Triumvirate" of cannabinoid, opioid and TRPV1 receptors.

Ferenc Zádor1, Maria Wollemann2.   

Abstract

A growing amount of data demonstrates the interactions between cannabinoid, opioid and the transient receptor potential (TRP) vanilloid type 1 (TRPV1) receptors. These interactions can be bidirectional, inhibitory or excitatory, acute or chronic in their nature, and arise both at the molecular level (structurally and functionally) and in physiological processes, such as pain modulation or perception. The interactions of these three pain-related receptors may also reserve important and new therapeutic applications for the treatment of chronic pain or inflammation. In this review, we summarize the main findings on the interactions between the cannabinoid, opioid and the TRPV1 receptor regarding to pain modulation.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cannabinoid receptor; Opioid receptor; Pain; Receptor interaction; TRPV1 receptor

Mesh:

Substances:

Year:  2015        PMID: 26520391     DOI: 10.1016/j.phrs.2015.10.015

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  6 in total

1.  Cannabinoids and Pain: Weeding Out Undesired Effects With a Novel Approach to Analgesia.

Authors:  Joao P De Aquino; David A Ross
Journal:  Biol Psychiatry       Date:  2018-11-15       Impact factor: 13.382

Review 2.  Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine.

Authors:  Gábor Nagy-Grócz; Ferenc Zádor; Szabolcs Dvorácskó; Zsuzsanna Bohár; Sándor Benyhe; Csaba Tömböly; Árpád Párdutz; László Vécsei
Journal:  Int J Mol Sci       Date:  2017-07-30       Impact factor: 5.923

Review 3.  Cannabinoids and Pain: New Insights From Old Molecules.

Authors:  Sonja Vučković; Dragana Srebro; Katarina Savić Vujović; Čedomir Vučetić; Milica Prostran
Journal:  Front Pharmacol       Date:  2018-11-13       Impact factor: 5.810

4.  Enhancement of Meditation Analgesia by Opioid Antagonist in Experienced Meditators.

Authors:  Lisa M May; Peter Kosek; Fadel Zeidan; Elliot T Berkman
Journal:  Psychosom Med       Date:  2018 Nov/Dec       Impact factor: 4.312

5.  Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors.

Authors:  Adriano Mollica; Sveva Pelliccia; Valeria Famiglini; Azzurra Stefanucci; Giorgia Macedonio; Annalisa Chiavaroli; Giustino Orlando; Luigi Brunetti; Claudio Ferrante; Stefano Pieretti; Ettore Novellino; Sandor Benyhe; Ferenc Zador; Anna Erdei; Edina Szucs; Reza Samavati; Szalbolch Dvrorasko; Csaba Tomboly; Rino Ragno; Alexandros Patsilinakos; Romano Silvestri
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

Review 6.  Fentanyl Structure as a Scaffold for Opioid/Non-Opioid Multitarget Analgesics.

Authors:  Piotr F J Lipiński; Joanna Matalińska
Journal:  Int J Mol Sci       Date:  2022-03-02       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.